EUR 0.3
(7.19%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | -11.5 Million EUR | -63.66% |
2022 | 16.51 Million EUR | -34.99% |
2021 | 25.39 Million EUR | 27.51% |
2020 | 19.92 Million EUR | 208.66% |
2019 | -18.33 Million EUR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 Q1 | 1643.00 EUR | -24.02% |
2023 FY | 6 Million EUR | -63.66% |
2023 Q2 | 1643.00 EUR | 0.0% |
2022 FY | 16.51 Million EUR | -34.99% |
2022 Q4 | 2162.50 EUR | 0.0% |
2021 FY | 25.39 Million EUR | 27.51% |
2020 FY | 19.92 Million EUR | 208.66% |
2019 FY | -18.33 Million EUR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
European Medical Solutions | 13.64 Million EUR | 184.29% |
FERMENTALG | 12.34 Million EUR | 193.187% |
PHAXIAM Therapeutics S.A. | 24.98 Million EUR | 146.038% |